Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
The next leg of the rebound may be more selective
Tesla Inc. (NASDAQ:TSLA) and Palantir Technologies Inc. (NASDAQ:PLTR) fell Wednesday even as a benign July inflation report lifted the broader tech market and sent the odds of a September Federal Reserve rate hike to 33%. Headline CPI rose 0.1% in...
SpaceX shares soared after Elon Musk revealed AI could soon become the company's biggest revenue driver. But with heavy spending and a lofty valuation, is the excitement justified?
What the market is paying less for in Accenture stock, and what the company is spending nine billion dollars to change.
Bloom Energy's 143% YTD surge, AI-driven power demand and rising earnings estimates support the stock despite its premium valuation.
One fund targets pharma exclusively and surged 63% in a year, while the other diversifies across healthcare with lower volatility.
Goldman Sachs (GS) is buying exchange-traded fund (ETF) provider NEOS Investments for $2.3 billion, following the firm's acquisition of Innovator ETFs in April. In the backdrop, over 900 ETFs have launched in the US so far this year — nearing record levels. Strategas Asset Management's chief ETF strategist, Todd Sohn, discusses the larger ETF space and explains the reasoning behind Goldman's ETF strategy.
July inflation came in exactly as expected, and stocks rallied for about half an hour. Here's what actually moved the market after that.
Schwab offers broader diversification with 121 holdings and lower costs, while State Street diversifies away from REITs and delivers higher income at 3.2%.
Consensus growth takes only a modest slice off the multiple, and the company has not yet set the instrument pricing that lands inside those two years.
Micron investors are feeling bullish thanks to new demand indicators and other factors.
VanEck targets established pharma giants with lower costs and volatility, while Invesco pursues high-growth biotech companies. One delivered stronger returns; the other weathered downturns better.
Stocks Rise After July CPI Report. Why the AI Trade Is Back in Focus
Should stock investors start selling now? History offers some lessons.
JPMorgan raised its index and earnings forecasts as AI spending translated into faster cloud revenue and larger corporate backlogs.
The GPU leader's stock price action has been displaying a pattern in recent years that suggests what to expect for the rest of 2026.
The market is having a strongly bullish reaction to CoreWeave's latest quarterly report.
By Avinash P and Purvi Agarwal Aug 12 (Reuters) - The S&P 500 and the Nasdaq rose on Wednesday as upbeat earnings from AI infrastructure firms boosted technology stocks, while largely in-line
This ETF offers investors a rare balance of growth, value, and income stocks.
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Opportunity Fund”. A copy of the letter is available to download here. During the second quarter, the Baron Opportunity Fund increased 27.07% (Institutional Shares), outperforming both the Russell 3000 Growth Index (17.05%) and the S&P 500 Index (15.20%). For the […]
In today's Chart of the Day, Yahoo Finance Markets & Data Editor Jared Blikre breaks down the tech market’s latest reset, why valuations are becoming more attractive even as earnings remain strong, and what it could mean for the broader bull market heading into the end of the year.
The company says it will buy Neos Investments, which specializes in funds that use options-based strategies to generate income.
The Dow Jones Industrial Average was down 22 points, after rallying at the open. Optical networking and chip stocks were also rallying. Consumer discretionary, communication services, materials, energy, and health care were the laggards, while tech, real estate, and utilities were leading at the sector level.